BCRX

BioCryst Pharmaceuticals, Inc.NASDAQHealthcare

$9.02-3.84%ClosedMarket Cap: $1.89B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-01-30	RBC Capital	—	Outperform	—
2025-12-15	HC Wainwright & Co.	—	Buy	—
2025-11-05	Citizens	—	Market Outperform	—
2025-11-04	Needham	—	Buy	—
2025-11-04	Barclays	—	Equal Weight	—
2025-10-15	Cantor Fitzgerald	—	Overweight	—
2025-10-15	JMP Securities	—	Market Outperform	—
2025-08-04	Needham	—	Buy	—
2025-07-01	B of A Securities	—	Buy	—
2025-06-30	Wedbush	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$0.47	$739.5M	5
Sun Dec 31	$0.46	$874.9M	4
Mon Dec 31	$1.02	$1.08B	2
Tue Dec 31	$1.63	$1.30B	2